13 Comments
User's avatar
Heike Larson's avatar

A key incentive missing is lower insurance rates for people who do all the things needed to stay healthy. Like: wear a CGM, get your blood sure under control without medication via lifestyle choice > CGM cost refunded and a credit toward next year’s insurance cost. Or walk an average of 10,000 steps a day as measured by a wearable you wear >90% of all days > a 5% reduction in your insurance rate.

My understanding is that the ACA makes that practically impossible as only smoking can directly impact rates.

If people paid less in insurance if the lived healthy lifestyles then that works better align incentives!

Deb Williams's avatar

The problem is not doing it may impose a cost for others Stage 1 breast cancer may be less expensive than later stages plus the costs from mixed work.

The bar that USPTF raised that it be cost effective, have robust evidence and also be worth clinicians time was meaningful. I went thru the process for the HepC drugs. It worked - terrible proposal and good final.

This is more of a discussion for those activities that don’t meet that bar or predate that process.

We all move forward, including economics from Milton Friedman. (Aka behavioral economics is more de rigeur, it’s doctors who seem to still quote Milton not monetary experts or health economists. Although he did have useful things that speak to me about evaluating public programs and some of his monetary theory has held I suppose.)

Anthony DiGiorgio, DO, MHA's avatar

I agree that catching stage 1 breast cancer early is less expensive. Which is why I included the OneNebraska example. Private companies are great at evaluating these tradeoffs and incentivizing that behavior. That's different than the government saying nobody should pay for any healthcare because they might have to cut back on vacation expenses.

Deb Williams's avatar

Exactly and I would rather have a robust clinical backed USPTF than have state and Federal legislation without evidence. It’s not a fear it’s a reality. Take prostate cancer screening (assuming I remember this correctly). They moved it up. But in the mean time more black men turned up with regional or distance prostate cancer. States started legislating on it. Clinicians were waiting for more evidence on the genetics and why. Finally USPTF looked at it again.

It’s so interesting to me. When I was 30 we were all influenced by Victor Fuchs who said prevention doesn’t save money. Eventually the data built up and changed and yes some does and that is why we got USPTF. So for someone in my age group I have watched this whole evolution.

Anthony DiGiorgio, DO, MHA's avatar

I was under the impression USPTF doesn't take cost into consideration (https://www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/USPSTF-cost-considerations-2025-update.pdf).

Regardless, I want cost conscious solutions, but I just trust the private sector to do those more effectively than government. My concern is that when coverage policy operates through a political process, evidence competes with lobbying, carve-outs and bargaining. I'm sure you have insights on this process.

USPTF could be a great advisory body for insurance plans that want to incentivize healthy, cost-saving behavior. We really should be doing that, and going even further. I'd love if private plans incentivized going to the gym and eating healthy (two things far more cost effective than cancer screening).

Also, I'm wary of studies with oberservational data only, such as the catastrophic plan cancer study. That piece had plenty of flaws.

Deb Williams's avatar

Yes it does not include cost but it is a cost conscious discussion in my experience. It had been firewalled (even more than the FDA advisory groups) from lobbying including no open meetings, now I don’t know as there are new members that also contract for research with Pharma. It did include a vigorous public comment process. My only prior objection with it was of course primary care driven but not all of the questions are around primary care, and it’s so very complicated as you know.

As far as the private sector I have sat on a number of advisory groups with the pharmacy directors of the plans and they dont have the band width. There are just some things it makes sense that the government does that have a wide benefit. For example it hosts the an and b billing claim forms committees, We could probably come up with a hundred other things they should not be doing but that doesnt mean it never is the case. For example cms doing CPT coding which requires up to date technical knowledge I am in the no camp. I am also in the no camp in the ICD 10 coding clinic which is run by hospital association.

Anthony Michael Perry's avatar

Not sure whether giving every woman screening mammograms really saves money. That seems like a complicated question and I'm too lazy to look it up. But that's beside the point if it saves lives. One thing I know is that paying for screening mammograms through third parties increases their price which we all have to pay collectively so what are we really gaining.

So, is the argument that if we don't pay for them through third parties that women won't get them? I'm not sure that making them more expensive is a good solution to that issue. But my view is that we're so used to a system of paying indirectly that we don't really know what the end result would be if we did it the other way around.

First of all, who knows where the cost would finally come out in a world where radiology businesses were competing to get customers through price and innovation. What would be the result if providers innovated to fit the technology to the problem at as low a cost as possible.

Secondly what would the response of women be to this situation in which the responsibility to possibly prevent breast cancer death rested on their decision. I suspect it would, over time in accommodating to this new public experience, be much different than what it is today. We would find out but I suspect it would be beneficial.

I'm not against insurance, just not insurance for lower cost expected items. It's really dumb to have that arrangement. Of course, there would be some women who would be conflicted about the cost. Solutions through the government would be an option - the accompanying waste and fraud would be tolerable on a limited scale. And then there's charity - which has been largely replaced by government for decades - but I think would be a major player for this type of issue.

Deb Williams's avatar

The USPTF mamo recommendations are age rated based on the evidence. However it is true that based on the community there was legislation to move the age bracket I am less familiar with the latter.

I think paying for items so cost is not a barrier where there is cost effective evidence makes sense. We can see that for former cancer patients in catastrophic plans there have higher mortality.

Charity has been proven over and over to be a terrible plan. And prevention is really a tiny part of cost a couple of percentage points.

High cost or low cost is a terrible benchmark, evidence should be the benchmark. Why is that even debatable? If it costs a dollar and saves a 1000 pay for it. If it costs a dollar and does nothing don’t.

Anthony Michael Perry's avatar

No problem with third party help for those who are truly needy, and I don't agree that charity couldn't be an important component, but that's another matter. My problem is with third party payment for the majority who aren't in unusual need. What is the benefit? What it does is raise the cost for everyone by elimination of market forces. So, if we stopped making it "free" what would happen? What about women for whom the test is affordable but choose not to have it? Would they have it if it was "free" and could spend the money on some alternative? I don't think either you or I know that. You might say that if a "free" test was an inducement that society would benefit. But neither of us know that either.

But a fundamental principle of economics is that "price" and "cost" are different. The cost of anything is what alternatives those resources could be used for, so if we make something "free" it is paid for by some other method using resources that could be used for something else of value. So, what I do think is correct is that making the price higher by making it "free" is bad policy for everybody, including those who are receiving third party assistance.